Following children with eosinophilic esophagitis over time and their quality of life
Follows children with eosinophilic esophagitis over 24 months, including their quality of life.
Key facts
- Who runs it
- Fondation Lenval
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Outcome of Children With Eosinophilic Esophagitis
- Status
- Not yet recruiting
- People taking part
- 16 people, planned
- Started
- Mar 2024
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Digestive endoscopy
- Record updated
- 16 January 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with eosinophilic esophagitis who are about to start treatment. They will be followed for 24 months, including their quality of life.
- Age
- 2 Years to 17 Years
- Sex
- All
- Disease stage
- Eosinophilic esophagitis, diagnosed by the criteria of the PNDS published in July 2022.
- Earlier treatment
- Children must be about to start treatment.
Main reasons for not taking part
- No consent from one of the 2 parents or the legal guardian
- Not covered by a social security scheme
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Diagnosis of OE according to the diagnostic criteria of the PNDS published in July 2022
- Due to start treatment
- informed consent from one of the 2 parents or the representative of parental authority
- Membership of a social security scheme
Who cannot take part
- -
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 17 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study their evolution at 3 months, 6 months, 12 months, 18 months and 24 months.
Read full original descriptionShow less
This study would also enable us to investigate the quality of life of these chronically ill patients
The group in the trial
- Management of eosinophilic esophagitisOther group
Follow-up visits are always organized in the same way. A consultation with a gastropediatrician will take place, with assessment of symptoms (PEESS score) and quality of life (PedsQL module for eosinophilic esophagitis and PedsQL 4.0 Generic Core Scales). Then, if treatment needs to be introduced or changed, a digestive endoscopy with biopsies will be carried out at 3 months to determine whether the patient is in remission or not. Depending on the results, the patient may be advised to adapt or maintain the current treatment.
Treatment: Digestive endoscopy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Outcomes of Children With Eosinophilic Esophagitis: a Prospective Monocentric Observational Study
- Plain-language title
- Following children with eosinophilic esophagitis over time and their quality of lifeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06190080, who can take part
- Record updated
- 16 January 2024